Vaccinogen Inc (VGEN) 0.9800 $VGEN Vaccinogen Believes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vaccinogen Inc (VGEN) 0.9800 $VGEN

Vaccinogen Believes That Its "Whole-Tumor Methodology" and Focus on "Cancer Heterogeneity" is Supported by Research Published in The Proceedings of the National Academy of Sciences (PNAS)
PR Newswire - Wed Dec 02, 6:33AM CST
Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, believes that an article published in The Proceedings of the National Academy of Sciences (PNAS) strongly supports the central thesis for the Company's OncoVAX® cancer immunotherapy platform and its whole-tumor methodology.

Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer
PR Newswire - Wed Nov 04, 6:33AM CST
Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today announced the promotion of Peter Morsing, Ph.D., to the position of Chief Operating Officer (COO). Dr. Morsing previously served as Vaccinogen's Global Head of Business Development & Strategy and is one of five Ph.D.'s that has joined the senior ranks of Vaccinogen in the last 13 months.

Vaccinogen Engages D. Barry Boyd, M.D., M.S., as Senior Oncology Advisor
PR Newswire - Wed Oct 28, 6:33AM CDT
Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today announced the engagement of D. Barry Boyd, M.D., M.S., to the newly established position of Senior Oncology Advisor and his appointment to the Company's Medical Advisory Board. Dr. Boyd is a specialist in the treatment of cancer and will provide expert counsel to Vaccinogen as the company pursues its ACTIVE Phase IIIb OncoVAX® clinical trial and expands its human antibody program (HuMabs).

Vaccinogen Appoints Michael G. Hagerman to its Board of Directors
PR Newswire - Tue Oct 06, 6:33AM CDT
Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today announced the appointment of Michael G. Hagerman, Cofounder and Partner of ACT Medical Solutions Inc. to its Board of Directors.

Vaccinogen Enhances Patient-Derived Antibody Program with Revolutionary High-Throughput Single Cell Screening and Analysis System
PR Newswire - Wed Sep 09, 6:33AM CDT
Vaccinogen, Inc. ("Vaccinogen" (OTC.QB: VGEN), a cancer immunotherapy development company, announced today it has entered into an exclusive option agreement with Dublin City University (DCU), through one of its subsidiaries, that provides the Company with an exclusive two-year option to evaluate and acquire a revolutionary high-throughput, multiplex, analysis platform - DiCAST. In conjunction with the agreement, the scientific team that developed DiCAST, including the lead inventor, Dr. Paul Leonard, has joined Vaccinogen and will spearhead the Company's operations in Ireland, a critical component of its global translational research strategy.

Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board
PR Newswire - Tue May 05, 6:00AM CDT
Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy development company, today announced that its Board of Directors has unanimously elected Co-founder, President, Chief Executive Officer and current Director, Andrew L. Tussing, to the role of Chairman of the Board. Mr. Tussing replaces Benjamin S. Carson, Sr., MD, who resigned from the Board and his role as Chairman and a member of Vaccinogen's Medical Advisory Board role to pursue his candidacy for the President of the United States via the Republican nomination.

Vaccinogen Elects Ronald Kaiser to Board of Directors
PR Newswire - Tue Feb 17, 6:00AM CST
Vaccinogen, Inc., (OTC.QB: VGEN) a leading cancer immunotherapy company, announced today that Ronald W. Kaiser, a biotech executive leader with more than 35 years of financial and accounting expertise, has been elected to the company's Board of Directors. Mr. Kaiser will also chair the company's Audit Committee and serve on the company's Nominating and Corporate Governance Committees.

Vaccinogen Names Dr. Peter Morsing as Head of Business Development
PR Newswire - Mon Jan 12, 8:00AM CST
Vaccinogen, Inc., (OTC.QB: VGEN) a leader in cancer immunotherapy development, announced today that Peter Morsing, Ph.D., a 20-year pharmaceutical industry veteran, has joined the company as Head of Business Development.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 10

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Zero Networks Welcomes New Leadership Driving Innovation

Updated Category News Views 307

Zero Networks Expands Leadership Team to Bolster Growth Zero Networks, a pioneer in zero trust security solutions, is excited to announce the addition of three new leaders to its team. These appointments aim to enhance product innovation and operational efficiency. Albert Estevez Polo has been named as Field CTO, while Moshe Strenger takes on the role of Vice President of...

Continue Reading
Matthew M. Caverly, PhD: A Pinnacle of Excellence in Academia

Updated Category News Views 180

Celebrating Academic Excellence In the realm of academic achievement, Dr. Matthew M. Caverly, PhD, has recently been recognized as a Pinnacle Professional Member by The Inner Circle. This esteemed acknowledgment is a testament to his significant contributions to political science education, particularly at a leading educational institution. Contributions to Education Dr....

Continue Reading
Market Sentiment Shifts: Analyzing QuantumScape's Short Interest

Updated Category News Views 193

Market Moves: The Short Interest Dilemma Jumping into today's fray with QuantumScape Corp (NYSE:QS) and their rising short interest—now sitting at a troublesome 12.87% of available shares. That's 62.92 million shares sold short, pushing the total up by over three and a half percent since the last reporting. What does this tell us? Traders are either paving the way for a...

Continue Reading
Embracing Technology for a Promising Restaurant Future

Updated Category News Views 341

Embracing Technology for a Promising Restaurant Future The restaurant franchise industry has faced numerous challenges over the last five years. However, optimism is rising, largely thanks to the integration of digital solutions, enhanced creativity in menus, and advances in artificial intelligence (AI). A recent survey by TD Bank highlights the expectations of restaurant...

Continue Reading
UPAY Inc. Champions Microfinance Sector Through ACPAS Support

Updated Category News Views 111

UPAY Inc. Champions the Microfinance Sector Through ACPAS Support UPAY Inc. (OTCQB: UPYY) proudly announces that its subsidiary, ACPAS, has sponsored an important Compliance Workshop for microfinance professionals. This event took place at a prominent venue, gathering key figures from the industry to discuss vital topics related to compliance and regulatory practices. The...

Continue Reading